Citigroup’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.5K Buy
8,930
+8,336
+1,403% +$28.3K ﹤0.01% 5104
2026
Q1
$2.48K Buy
594
+339
+133% +$1.41K ﹤0.01% 5399
2025
Q4
$1.1K Buy
255
+179
+236% +$683 ﹤0.01% 5539
2025
Q3
$329 Sell
76
-1,825
-96% -$8.23K ﹤0.01% 5737
2025
Q2
$8.82K Buy
+1,901
New +$7.52K ﹤0.01% 5209

Other funds holding SBC

Citigroup's SBC Position: Q2 2026 in Review

Citigroup increased its SBC Medical Group (SBC) stake by 1,403% in Q2 2026, buying an estimated $28.3K and bringing the position to 8,930 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5104.

Citigroup first reported a position in SBC in Q2 2025 and has held it in 5 quarters since. 12 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Citigroup held 8,930 shares of SBC Medical Group worth $27.5K as of Q2 2026.
  • Citigroup bought 8,336 SBC Medical Group shares in Q2 2026, an estimated $28.3K.
  • SBC Medical Group made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5104 holding.
  • Citigroup first reported a position in SBC Medical Group in Q2 2025 and has held it in 5 quarters since.
  • 12 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.